The rising interest in GLP-1 agonists for diabetes has sparked a debate about application forms : skin-applied devices versus capsules. Usually , GLP-1 treatments were only available in oral form, but the https://blakegwxy949593.vblogetin.com/47044328/glp-1-transdermal-delivery-systems-vs-pills-which-right-for-individuals